Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0239 per EA under NDC 49483062181. Its NADAC has been published 478 times since Jun 28, 2017.
FDA first approved this application on Mar 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483062181
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090888FDA Approved
3/12/2012
TE Code
AB
On Market Since
11/14/2016
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 478 times since Jun 28, 2017, and over the history we have for it it has declined 23.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0239 per EA |
|---|---|
| All-time high | $0.0325 (Oct 11, 2017) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0279 |
| Average price | $0.0273 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 478 |
| Tracking since | Jun 28, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0239 per EA (NDC 49483062181), effective Aug 19, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 23.1%. It has been tracked across 478 weekly CMS publications since Jun 28, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Jun 28, 2017, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0325 (Oct 11, 2017), with a median of $0.0279 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 49483062181) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.